Transfusion thresholds and other strategies for guiding red blood cell transfusion

医学 背景(考古学) 红细胞输注 输血 危害 临床试验 梅德林 重症监护医学 心肌梗塞 儿科 需要伤害的数量 急诊医学 荟萃分析 红细胞 输血医学 输血疗法
作者
Jeffrey L. Carson,Simon J. Stanworth,Jane A Dennis,Dean A. Fergusson,Monica B. Pagano,Nareg H. Roubinian,Alexis F. Turgeon,Stacey L. Valentine,Marialena Trivella,Carolyn J. Doree,Paul C. Hébert
出处
期刊:The Cochrane library [Wiley]
卷期号:2025 (10): CD002042-CD002042 被引量:49
标识
DOI:10.1002/14651858.cd002042.pub6
摘要

BACKGROUND: The optimal haemoglobin threshold for use of red blood cell (RBC) transfusions in anaemic patients remains an active area of research. Blood is a limited resource, and there are concerns about risks, including transmitted infections. If a liberal transfusion strategy does not improve clinical outcomes, or if it is equivalent, then adopting a more restrictive approach should be recognised as the standard of care. OBJECTIVES: The aim of this review update was to compare 30-day mortality and other clinical outcomes for participants randomised to restrictive versus liberal red blood cell (RBC) transfusion thresholds (triggers) for all clinical conditions. The restrictive transfusion threshold uses a lower haemoglobin concentration as a threshold for transfusion (most commonly, 7.0 g/dL to 8.0 g/dL), and the liberal transfusion threshold uses a higher haemoglobin concentration to direct transfusion (most commonly, 9.0 g/dL to 10.0 g/dL). Increasingly, investigators are considering other strategies including physiological triggers (i.e. central venous oxygen saturation), alone or in combination with such thresholds, to determine when a transfusion is indicated, so it is important to assess this growing body of evidence in tandem. SEARCH METHODS: We searched CENTRAL, MEDLINE, Embase, Transfusion Evidence Library, Web of Science Conference Proceedings Citation Index, trial registries and PubMed on 14 October 2024. We checked reference lists of published reviews and papers for additional trials. SELECTION CRITERIA: We included randomised trials of surgical or medical participants that recruited adults or children. We excluded studies that focused on preterm neonates. Eligible trials assigned intervention groups based on different transfusion strategies or thresholds, usually defined by a haemoglobin concentration below which a RBC transfusion would be administered. We included trials in which investigators had allocated participants to higher thresholds or more liberal transfusion strategies compared to more restrictive ones, which might include no transfusion. DATA COLLECTION AND ANALYSIS: We used standard Cochrane methods. We pooled risk ratios across trials using a random-effects model. We assessed risk of bias using the Cochrane RoB 1 tool, and assessed the certainty of evidence using GRADE. We defined participants randomly allocated to the lower transfusion threshold as being in the 'restrictive transfusion' group and those randomly allocated to the higher transfusion threshold as being in the 'liberal transfusion' group. MAIN RESULTS: Adult threshold comparison We included 61 trials (27,639 participants), across a range of clinical contexts: orthopaedic, cardiac or vascular surgery; critical care; neurocritical care; gastrointestinal bleeding; trauma; acute myocardial infarction; haematological malignancies and postpartum haemorrhage. The haemoglobin concentration used to define the restrictive transfusion group in most trials was between 7.0 g/dL and 8.0 g/dL. The main outcomes were exposure to blood transfusion, 30-day mortality, neurologic function, myocardial infarction, congestive heart failure, cerebral vascular accident, infection and thromboembolism. Studies were generally at low risk of bias. Restrictive transfusion strategies reduced the risk of receiving at least one RBC transfusion by 42% when combining all clinical contexts (risk ratio (RR) 0.58, 95% confidence interval (CI) 0.52 to 0.65; high-certainty evidence), with a large amount of heterogeneity between trials (I² = 97%), reflecting diversity in the strength of estimates, not the efficacy of the policy. When combining all clinical contexts, restrictive transfusion strategies did not modify the risk of 30-day mortality compared with liberal transfusion strategies (RR 1.01, 95% CI 0.90 to 1.14; 44 studies, 22,575 participants; high-certainty evidence) or any of the other outcomes assessed including myocardial infarction, stroke, thromboembolism or infection (moderate to high-certainty evidence). There were two exceptions in clinical populations. In gastrointestinal bleeding, 30-day mortality was lower with a restrictive transfusion strategy (RR 0.63, 95% CI 0.42 to 0.95; 4 studies, 1574 participants). In critically ill patients with brain injury, unfavourable neurological outcome at 6 to 12 months was lower with a liberal transfusion strategy (RR 1.14, 95% CI 1.05 to 1.22; 4 studies, 2297 participants) (moderate-certainty evidence). Transfusion-specific reactions are uncommon, but occurred more frequently with the liberal strategy (Peto odds ratio 0.47, 95% CI 0.36 to 0.62; 18 studies, 11,505 participants). Paediatric threshold comparison We included eight trials (2764 participants), across a limited range of clinical contexts (critical care, cardiac surgery, haematological malignancies and severe malarial anaemia). The haemoglobin concentration used to define the restrictive group in critical care and haematological malignancies trials was between 6.5 g/dL and 8.0 g/dL, and between 7.0 g/dL and 9 g/dL in cardiac surgery trials, depending on the cardiac abnormality and stage of repair. Studies were generally at low risk of bias. There was no clear difference in 30-day mortality between restrictive and liberal transfusion strategies, although confidence intervals were wide (RR 1.22, 95% CI 0.72 to 2.08; 7 studies, 2571 participants; low-certainty evidence). There was moderate-certainty evidence of no clear difference between threshold strategies for infection; very low-certainty evidence of little to no difference for thrombosis and very low-certainty evidence of little to no difference for the outcomes multiple organ dysfunction and cerebrovascular accident. Physiological triggers Nine trials in adults (3818 participants) and one trial in children (100 participants) were identified. These tested different interventions and measures of physiological parameters in diverse clinical populations. The risk of bias was variable. Meta-analysis was not appropriate due to heterogeneity. AUTHORS' CONCLUSIONS: A restrictive transfusion strategy significantly decreased the proportion of adults and children exposed to RBC transfusion. In most clinical contexts, there was no evidence of harm from a restrictive compared with a liberal transfusion strategy. Neurocritically ill patients, however, have better neurological outcomes at 6 to 12 months with a liberal transfusion strategy. Further work is needed to improve our understanding of outcomes beyond mortality, and to what degree the optimal strategies for transfusion should be modified in some patient populations, including different types of acute bleeding, cancers and subgroups of patients with myocardial infarction and other neurological injuries. New studies need to recognise the clinical context and the limitations of the adoption of a single threshold of haemoglobin, and to consider evaluating the use of physiological parameters to modify transfusion.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
朱朱发布了新的文献求助10
刚刚
sin完成签到 ,获得积分10
刚刚
斑马兽完成签到,获得积分10
1秒前
乐乐的应助被gaoyi12356采纳,获得10
1秒前
YXH给YXH的求助进行了留言
2秒前
3秒前
3秒前
liu45kf完成签到,获得积分10
3秒前
kongqing完成签到,获得积分10
3秒前
拼搏的大地完成签到,获得积分10
3秒前
mzn6664发布了新的文献求助10
4秒前
黄毛虎发布了新的文献求助10
4秒前
5秒前
阿北洛完成签到,获得积分10
7秒前
7秒前
Jasper的应助被gaoyi12356采纳,获得10
8秒前
ian发布了新的文献求助10
8秒前
彤航完成签到,获得积分10
9秒前
9秒前
吱吱发布了新的文献求助10
9秒前
Qin完成签到,获得积分0
9秒前
9秒前
七七发布了新的文献求助10
11秒前
所所的应助被鸡翅爱睡觉采纳,获得10
11秒前
luan发布了新的文献求助10
12秒前
牛哞完成签到,获得积分10
13秒前
德烁完成签到,获得积分10
13秒前
13秒前
小洁完成签到 ,获得积分0
13秒前
Yana完成签到,获得积分10
14秒前
zpl完成签到,获得积分10
14秒前
15秒前
黄毛虎发布了新的文献求助10
15秒前
火星上的煎蛋的应助被小SCI采纳,获得10
15秒前
dxftx发布了新的文献求助10
16秒前
秋风的应助被leotao采纳,获得10
17秒前
小溪苏完成签到 ,获得积分10
17秒前
18秒前
田様的应助被gaoyi12356采纳,获得10
18秒前
放鸿鸟于飞完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187480
求助须知:如何正确求助?哪些是违规求助? 9575554
关于积分的说明 21841909
捐赠科研通 7785230
什么是DOI,文献DOI怎么找? 3434949
关于科研通互助平台的介绍 2559412
邀请新用户注册赠送积分活动 2481898